← Leaderboards
Timothy E Sweeney
Inflammatix, Inc.
$2,252,971
Attributed
$2,252,971
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2021–23$2M$1.5M$1M$500K$0
'21
'22
'23
Funding mix
By agency
NIH$2,252,971 · 3
By mechanism
R44$1,701,838 · 1
R43$551,133 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Messenger Rna”
- Laura McNay · Leidos Biomedical Research, Inc.$15,147,252
- Norbert Pardi · University Of Pennsylvania$13,084,354
- Neil King · University Of Washington$12,677,393
- Kirsten Frieda · Spatial Genomics, Inc.$12,006,066
- Wilton B Williams · Duke University$11,389,307
- Julie Ake · National Institute Of Allergy And Infectious Diseases$10,950,000
Research focus
Messenger RnaGenetic SignatureSamplingValidationMachine LearningGenesProspective StudiesRetrospective CohortTrainingTranslatingTranscriptomicsClinically ActionableHeterogeneityResponseData SetMortalityCohort AnalysisPharmaceutical PreparationsBaseBloodCohortPhenotypeLibrariesLife
Grant awards (4)
Development of a multi-RNA signature in blood towards a rapid diagnostic test to robustly distinguish patients with acute myocardial infarction$299,762
R43 · FY2023 · HL · contact PI
Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes$1,017,950
R44 · FY2022 · GM · contact PI
Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes$683,888
R44 · FY2021 · GM · contact PI
DEVELOPMENT OF BASELINE GENE EXPRESSION-BASED RESPONSE PREDICTOR FOR ANTI-TNFA THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES$251,371
R43 · FY2021 · DK · contact PI